Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Noteableon Sep 05, 2024 11:36am
47 Views
Post# 36209939

RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China

RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and China

 The House Select Committee on the Chinese Communist Party launched a probe into Harvard's handling of an anti-CCP protest during a speech by Chinese Ambassador to the United States Xie Feng at the Harvard Kennedy School in April.

Chairman John R. Moolenaar (R-Mich.) wrote in a four-page letter to interim Harvard President Alan M. Garber ’76 that the protest — which resulted in the forcible removal of several protesters — raised concerns over whether Harvard is doing enough to “ensure students’ safety for freedom of expression.”

This incident raises serious questions regarding possible transnational repression by the Chinese government and the involvement of international students from China at Harvard in acts of harassment and intimidation condoned by the Chinese government against its critics,” Moolenaar wrote.

https://www.thecrimson.com/article/2024/7/2/house-select-committee-china-harvard-protest/

<< Previous
Bullboard Posts
Next >>